SEC 13F Intelligence

Sandell Asset Management Corp. / PCRX

Sandell Asset Management Corp.’s Pacira Biosciences Inc Position

Does Sandell Asset Management Corp. own Pacira Biosciences Inc (PCRX)? Not currently — the last reported position was 140.0K shares worth $6M in Q4 2019; the fund’s latest 13F (Q3 2020) no longer reports it.

Position Value
$6M
Q4 2019
Shares
140.0K
% of Portfolio
+1.03%
Quarters Held
5
position exited

Position History PCRX

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $5MQ1 ’19Q2 ’19: $6MQ2 ’19Q3 ’19: $5MQ3 ’19Q4 ’19: $6MQ4 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2019140.0K$6M+1.03%
Q3 2019140.0K$5M+1.79%
Q2 2019129.9K$6M+0.64%
Q1 2019129.9K$5M+0.88%
Q4 2018151.6K$7M+0.72%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sandell Asset Management Corp.’s full portfolio or all institutional holders of PCRX.